Standard curve
Example of Rat IL-10 standard curve in Assay Diluent .
Product Details
Product Details
Product Specification
| Antigen | IL-10 |
| Application | FCM |
| Reactivity | Rat |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8°C as supplied. |
Kit
| Precision | Intra-assay: 4.41% Inter-assay: |
| Sample type | Serum; Plasma-EDTA; Plasma-Heparin; Plasma-Citrate; Cell Culture Supernatant |
| Assay type | Sandwich (quantitative) |
| Sensitivity | 1.30 pg/mL |
| Range | 7.13 pg/mL-5200 pg/mL |
| Assay time | 70 minutes |
| Species reactivity | Rat |
Background
Interleukin-10 (IL-10), also known as cytokine synthesis inhibitory factor (CSIF), is a key anti-inflammatory and immunoregulatory cytokine essential for maintaining immune homeostasis and limiting host tissue damage. Biologically active rat IL-10 forms a non-covalent, V-shaped homodimer composed of two identical 160-amino-acid monomers (~18 kDa unglycosylated), each stabilized by two intramolecular disulfide bonds and carrying an N-linked glycosylation site absent in human IL-10. Signaling through the IL-10R1/IL-10R2 receptor complex, it activates the JAK1/TYK2–STAT3 pathway. Secreted primarily by regulatory T cells (Tregs), Th2 cells, monocytes, macrophages, and B cells, IL-10 suppresses pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6, IFN-γ) and antigen presentation while supporting B-cell survival and mucosal integrity. Although mature rat IL-10 shares ~85% sequence identity with mouse IL-10 and ~73% with human IL-10, species-specific epitopes and glycosylation require rat-specific detection. In basic and preclinical research, quantifying rat IL-10 in serum, plasma, or cell culture supernatants serves as an essential biomarker for investigating inflammatory and autoimmune disease models (such as colitis, arthritis, and sepsis), tissue repair, transplant tolerance, and the efficacy or immunotoxicity of candidate therapeutics.
Picture
Picture
CBA
Dilution Linearity
Spiked serum and plasma (EDTA, Heparin, Citrate) samples from SD, SHR, and Lewis rats, along with spiked cell culture supernatant, were pre-diluted 1:1 (v/v) with sample diluent (labeled as "Undiluted") and then serially diluted 2X, 4X, and 8X with sample diluent prior to assaying for Rat IL-10. Data shown on the y-axis represent the measured Rat IL-10 concentrations multiplied by their respective serial dilution factors (pg/mL).
Accuracy and Spike Recovery
Serum and plasma (EDTA, Heparin, Citrate) matrices from SD, SHR, and Lewis rats—pre-diluted 1:1 (v/v) in sample diluent—along with cell culture supernatant, were spiked with high, medium, and low levels of Rat IL-10. The y-axis displays the calculated spike recovery percentages (Spike Recovery%) across each tested matrix, demonstrating consistent recovery performance across different rat strains and biological matrices.
Sample Reactivity
Cell culture supernatants from rat splenocytes left untreated or stimulated with 1 μg/mL LPS for 24 h (n = 3) were assayed for Rat IL-10 (pg/mL). Mean Rat IL-10 concentrations increased from 95.6 pg/mL in untreated controls to 2761.1 pg/mL in LPS-treated cells. Data are presented as mean ± SD.
Protocol Diagram
